Contract Research Organization WCCT Global Announces Completion of Second CKD PK Study Including Renal Dialysis Cohorts in 2013
Costa Mesa, Ca (PRWEB) October 25, 2013 -- WCCT Global, a full service contract research organization announced today the organization has successfully completed its second pharmacokinetic clinical trial during 2013 in patients with stable chronic renal disease. Both studies included patients with varying degrees of kidney dysfunction as well as patients requiring hemodialysis. WCCTG attributes its strong network of leading nephrologists in the Southern California area for their success in this difficult to recruit population. WCCT Global was approached by a well-known sponsor in 2012 to conduct a difficult study in the renal dialysis patients. By utilizing the WCCTG network of physicians and recruitment process, WCCT Global was able to successfully enroll and complete the study within the sponsor-requested timeline. The Investigator that worked with WCCT Global on this recent study stated, “I chose to work with WCCT Global on this renal dialysis clinical study because I knew they had the experience and qualifications to manage complex demands and logistics of the protocol and allow me to devote my time to my patients that were enrolled in the trial.”
More about WCCT Global:
WCCT Global is a multi-site, full service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today”, truly exemplifies the focus and reason for our cutting edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.
If you would like to request information about how WCCT Global can assist your organization with a clinical study, please CLICK HERE
Talia A. Nikolao, M.B.A., WCCT Global, LLC, http://www.wcct.com, 1.714.252.0700 2201, [email protected]
Share this article